|Class 3 semaphorins control vascular morphogenesis by inhibiting integrin function|
G Serini, D Valdembri, S Zanivan, G Morterra, C Burkhardt, F Caccavari, ...
Nature 424 (6947), 391-397, 2003
|The chemokine system in cancer biology and therapy|
A Mantovani, B Savino, M Locati, L Zammataro, P Allavena, R Bonecchi
Cytokine & growth factor reviews 21 (1), 27-39, 2010
|Tumor-conditioned macrophages secrete migration-stimulating factor: a new marker for M2-polarization, influencing tumor cell motility|
G Solinas, S Schiarea, M Liguori, M Fabbri, S Pesce, L Zammataro, ...
The Journal of Immunology 185 (1), 642-652, 2010
|Differential regulation of iron homeostasis during human macrophage polarized activation|
S Recalcati, M Locati, A Marini, P Santambrogio, F Zaninotto, M De Pizzol, ...
European journal of immunology 40 (3), 824-835, 2010
|Role of c-MYC in alternative activation of human macrophages and tumor-associated macrophage biology|
OM Pello, M De Pizzol, M Mirolo, L Soucek, L Zammataro, A Amabile, ...
Blood, The Journal of the American Society of Hematology 119 (2), 411-421, 2012
|Gremlin is a novel agonist of the major proangiogenic receptor VEGFR2|
S Mitola, C Ravelli, E Moroni, V Salvi, D Leali, K Ballmer-Hofer, ...
Blood, The Journal of the American Society of Hematology 116 (18), 3677-3680, 2010
|Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial–mesenchymal transition|
S Zhao, S Bellone, S Lopez, D Thakral, C Schwab, DP English, J Black, ...
Proceedings of the National Academy of Sciences 113 (43), 12238-12243, 2016
|Epigenetic investigation of variably X chromosome inactivated genes in monozygotic female twins discordant for primary biliary cirrhosis|
MM Mitchell, A Lleo, L Zammataro, MJ Mayo, P Invernizzi, N Bach, ...
Epigenetics 6 (1), 95-102, 2011
|Type I collagen limits VEGFR-2 signaling by a SHP2 protein-tyrosine phosphatase–dependent mechanism 1|
S Mitola, B Brenchio, M Piccinini, L Tertoolen, L Zammataro, G Breier, ...
Circulation research 98 (1), 45-54, 2006
|RANK‐dependent autosomal recessive osteopetrosis: characterization of five new cases with novel mutations|
A Pangrazio, B Cassani, MM Guerrini, JC Crockett, V Marrella, ...
Journal of Bone and Mineral Research 27 (2), 342-351, 2012
|Genome-wide analysis of DNA methylation, copy number variation, and gene expression in monozygotic twins discordant for primary biliary cirrhosis|
C Selmi, F Cavaciocchi, A Lleo, C Cheroni, R De Francesco, SA Lombardi, ...
Frontiers in immunology 5, 128, 2014
|X chromosome gene methylation in peripheral lymphocytes from monozygotic twins discordant for scleroderma|
C Selmi, CA Feghali-Bostwick, A Lleo, SA Lombardi, M De Santis, ...
Clinical & Experimental Immunology 169 (3), 253-262, 2012
|Polymerase ε (POLE) ultra-mutation in uterine tumors correlates with T lymphocyte infiltration and increased resistance to platinum-based chemotherapy in vitro|
S Bellone, E Bignotti, S Lonardi, F Ferrari, F Centritto, A Masserdotti, ...
Gynecologic oncology 144 (1), 146-152, 2017
|A novel multiple biomarker panel for the early detection of high-grade serous ovarian carcinoma|
C Han, S Bellone, ER Siegel, G Altwerger, G Menderes, E Bonazzoli, ...
Gynecologic oncology 149 (3), 585-591, 2018
|Exceptional Response to Pembrolizumab in a Metastatic, Chemotherapy/Radiation-Resistant Ovarian Cancer Patient Harboring a PD-L1-Genetic RearrangementRegression of CD274 …|
S Bellone, N Buza, J Choi, L Zammataro, L Gay, J Elvin, DL Rimm, Y Liu, ...
Clinical Cancer Research 24 (14), 3282-3291, 2018
|NOTCH3 expression is linked to breast cancer seeding and distant metastasis|
AA Leontovich, M Jalalirad, JL Salisbury, L Mills, C Haddox, M Schroeder, ...
Breast Cancer Research 20 (1), 1-19, 2018
|Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors|
C Li, E Bonazzoli, S Bellone, J Choi, W Dong, G Menderes, G Altwerger, ...
Proceedings of the National Academy of Sciences 116 (2), 619-624, 2019
|SYD985, a novel duocarmycin-based HER2-targeting antibody-drug conjugate, shows promising antitumor activity in epithelial ovarian carcinoma with HER2/Neu expression|
G Menderes, E Bonazzoli, S Bellone, J Black, G Altwerger, A Masserdotti, ...
Gynecologic oncology 146 (1), 179-186, 2017
|Whole-exome sequencing of cervical carcinomas identifies activating ERBB2 and PIK3CA mutations as targets for combination therapy|
L Zammataro, S Lopez, S Bellone, F Pettinella, E Bonazzoli, E Perrone, ...
Proceedings of the National Academy of Sciences 116 (45), 22730-22736, 2019
|SYD985, a novel duocarmycin-based HER2-targeting antibody–drug conjugate, shows antitumor activity in uterine and ovarian carcinosarcoma with HER2/Neu expression|
G Menderes, E Bonazzoli, S Bellone, J Black, F Predolini, F Pettinella, ...
Clinical Cancer Research 23 (19), 5836-5845, 2017